Evidence map›Paper›PMID 32692837›Full record

ArticleThe international journal of neuropsychopharmacology2020

Differences in executive function among patients with schizophrenia, their unaffected first-degree relatives and healthy participants.

Yuzuru Kataoka, Takamitsu Shimada, Yoko Koide, Hiroaki Okubo, Takashi Uehara, Toshiki Shioiri, Yasuhiro Kawasaki, Kazutaka Ohi

Open access · goldAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Causal associations of intelligence with schizophrenia and bipolar disorder: A Mendelian randomization analysis.European psychiatry : the journal of the Association of European Psychiatrists · 2021
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yuzuru KataokaDepartment of Neuropsychiatry, Kanazawa Medical University, Ishikawa, Japan.
Takamitsu ShimadaDepartment of Neuropsychiatry, Kanazawa Medical University, Ishikawa, Japan.
Yoko KoideDepartment of Neuropsychiatry, Kanazawa Medical University, Ishikawa, Japan.
Hiroaki OkuboDepartment of Neuropsychiatry, Kanazawa Medical University, Ishikawa, Japan.
Takashi UeharaDepartment of Neuropsychiatry, Kanazawa Medical University, Ishikawa, Japan.
Toshiki ShioiriDepartment of Psychiatry and Psychotherapy, Gifu University Graduate School of Medicine, Gifu, Japan.
Yasuhiro KawasakiDepartment of Neuropsychiatry, Kanazawa Medical University, Ishikawa, Japan.
Kazutaka OhiDepartment of Neuropsychiatry, Kanazawa Medical University, Ishikawa, Japan.
Kanazawa Medical University · JPGifu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with schizophrenia (SCZ) display impaired executive functions compared with healthy controls (HCs). Furthermore, unaffected first-degree relatives (FRs) of patients with SCZ independently perform worse executive functions than do HCs. However, few studies have investigated the differences in executive functions assessed among patients with SCZ, FRs, and HCs, and the findings are inconsistent.

methodsWe investigated diagnostic differences in executive functions, namely, (i) numbers of categories achieved (CA), (ii) total errors (TE) and (iii) %perseverative errors of Nelson types (%PEN), using the Wisconsin card sorting test (WCST) among patients with SCZ (n=116), unaffected FRs (n=62) and HCs (n=146) at a single institute. Correlations between these executive functions and clinical variables were investigated.

resultsSignificant differences existed in all executive functions among diagnostic groups (CA, F2,319=15.5, p=3.71×10-7; TE, F2,319=16.2, p=2.06×10-7; and %PEN, F2,319=21.3, p=2.15×10-9). Patients with SCZ had fewer CA and more TE and %PEN than those of HCs (CA, Cohen's d=-0.70, p=5.49×10-8; TE, d=0.70, p=5.62×10-8; and %PEN, d=0.82, p=2.85×10-10) and FRs (TE, d=0.46, p=3.73×10-3 and %PEN, d=0.38, p=0.017). Of the three executive functions, CA and %PEN of FRs were intermediately impaired between patients with SCZ and HCs (CA, d=-0.41, p=0.011 and %PEN, d=0.41, p=0.012). In contrast, no significant difference in TE existed between FRs and HCs (d=0.22, p=0.18). Although CA and TE were affected by the duration of illness (p<0.017), %PEN was not affected by any clinical variable in patients with SCZ (p>0.017).

conclusionsExecutive function, particularly %PEN, could be a useful intermediate phenotype for understanding the genetic mechanisms implicated in SCZ pathophysiology.

Indexed as

executive functionfirst-degree relativesperseverative errorsSchizophreniaWisconsin card sorting test

Identifiers

PMID32692837
PMCPMC7745249
OpenAlexW3043982334

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.